Factors Likely to Have Influenced Earnings Results STAAR Surgical (NASDAQ:STAA)

Earnings results for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical Company is expected* to report earnings on 02/24/2021 after market close. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.09. The reported EPS for the same quarter last year was $0.12.

Analyst Opinion on STAAR Surgical (NASDAQ:STAA)

6 Wall Street analysts have issued ratings and price targets for STAAR Surgical in the last 12 months. Their average twelve-month price target is $61.17, predicting that the stock has a possible downside of 50.41%. The high price target for STAA is $84.00 and the low price target for STAA is $41.00. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”

STAAR Surgical has received a consensus rating of Buy. The company’s average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $61.17, STAAR Surgical has a forecasted downside of 50.4% from its current price of $123.34. STAAR Surgical has only been the subject of 2 research reports in the past 90 days.

Dividend Strength: STAAR Surgical (NASDAQ:STAA)

STAAR Surgical does not currently pay a dividend. STAAR Surgical does not have a long track record of dividend growth.

Insiders buying/selling: STAAR Surgical (NASDAQ:STAA)

In the past three months, STAAR Surgical insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $97,737,960.00 in company stock. Only 3.90% of the stock of STAAR Surgical is held by insiders. 85.35% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of STAAR Surgical (NASDAQ:STAA

Earnings for STAAR Surgical are expected to grow by 381.82% in the coming year, from $0.11 to $0.53 per share. The P/E ratio of STAAR Surgical is 649.19, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 33.34. The P/E ratio of STAAR Surgical is 649.19, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 42.84. STAAR Surgical has a P/B Ratio of 34.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here